| abstract |
The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosteronemediated diseases. The invention furthermore relates to specific diastereomers and enantiomers of the compounds, to processes for preparing compounds of the Formula (I), to their potential use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I). |